Partnerships
We are driven to make an impact in patient lives—and we innovate across the entire continuum of care in ways no other company can.
We boldly pursue transformational licensing, acquisition and collaboration opportunities that accelerate breakthrough innovation to prevent, treat and cure some of the world’s most challenging diseases, including those that have few or no effective treatments today. Our approach is rooted in trust and transparency, leading to long-term partnering success with a proven, positive track record of deal performance. These investments and collaborations continue to strengthen our pipeline with new, investigational assets like our targeted oral peptide, antibody drug conjugates (ADCs), next-generation chimeric antigen receptor (CAR) T-cell therapies and with breakthrough innovations that have reached patients.
We boldly pursue transformational licensing, acquisition and collaboration opportunities that accelerate breakthrough innovation to prevent, treat and cure some of the world’s most challenging diseases, including those that have few or no effective treatments today. Our approach is rooted in trust and transparency, leading to long-term partnering success with a proven, positive track record of deal performance. These investments and collaborations continue to strengthen our pipeline with new, investigational assets like our targeted oral peptide, antibody drug conjugates (ADCs), next-generation chimeric antigen receptor (CAR) T-cell therapies and with breakthrough innovations that have reached patients.
Collaborate with J&J Innovative Medicine
Interested in collaborating? Contact us with your idea.
For pre-proof-of-concept licensing opportunities or research collaborations, please visit the Johnson & Johnson Innovation team website.
For pre-proof-of-concept licensing opportunities or research collaborations, please visit the Johnson & Johnson Innovation team website.
You are now leaving jnj.com/innovativemedicine
This link will take you to a different Johnson & Johnson website, where different laws and regulations may apply.
Partnering disease areas
Through strategic partnerships and acquisitions, we deliver medicines for some of the world’s most challenging diseases, including those with few or no effective treatments today. We’re focused in areas where patient need is high, market opportunity is significant and our expertise is deep.
-
-
Immunology
Inspired by the promise of helping patients reclaim their lives, we are delivering transformational, accessible therapies and regimens to patients with autoimmune diseases. -
Neuroscience
We’re confronting neuroscience’s greatest challenges with purpose, resilience and precision. In a field defined by complexity and uncertainty, we remain steadfast in our pursuit of breakthroughs for patients who need them most. -
Discovery, product development and supply
From early discovery, non-clinical safety, clinical manufacturing and supply, our team covers the entire drug discovery and development process, crossing all modalities and support of J&J focus areas. -
Data science and digital health
We are reimagining the discovery and development of medicines that advance our mission of leading where medicine is going to transform health for humanity.
